Natco Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹647.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 52.51 per cent from ₹1,363.00 crore. This corresponds to a year-on-year *(YoY) growth of 36.33 per cent.
Operating Profit
Operating Profit stands at ₹158.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 72.60 per cent from ₹579.20 crore. This corresponds to a year-on-year *(YoY) growth of 309.02 per cent.
PBDT
PBDT stands at ₹218.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 67.24 per cent from ₹666.10 crore. This corresponds to a year-on-year *(YoY) growth of 3.56 per cent.
Profit Before Tax
Profit Before Tax stands at ₹172.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.97 per cent from ₹613.70 crore. This corresponds to a year-on-year *(YoY) growth of 5.07 per cent.
Net Profit
Net Profit stands at ₹151.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.79 per cent from ₹517.90 crore. This represents a 14.27 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Natco Pharma Ltd News
Natco Pharma Ltd Earnings
- YOY
- QOQ
Natco Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natco Pharma Ltd Research Reports
Natco Pharma Ltd Financial Reports
Natco Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natco Pharma | -0.49% | -0.94% | 5.71% | 30.43% | 33.66% | 36.56% |
| Astrazeneca Phar | 0.33% | 2.23% | 0.45% | -3.87% | -6.07% | 8.05% |
| Neuland Labs. | 1.59% | 0.78% | 9.04% | 31.04% | -0.80% | 48.74% |
| OneSource Speci. | 2.43% | 3.43% | 19.66% | 46.24% | 10.66% | 12.13% |
| ERIS Lifescience | 0.15% | 0.43% | -6.66% | -0.34% | -19.98% | -8.93% |
| Granules India | 2.31% | 2.46% | 12.68% | 25.22% | 35.85% | 46.99% |
| Rubicon Research | -0.58% | 4.74% | 6.68% | 26.83% | 42.72% | 58.12% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & Chief Executive Officer : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh